These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36054142)

  • 21. Understanding the relationship between freezing of gait and other progressive supranuclear palsy features.
    Rezvanian S; Litvan I; Standaert D; Jankovic J; Reich SG; Hall D; Shprecher DR; Bordelon Y; Dubinsky R; Kluger B
    Parkinsonism Relat Disord; 2020 Sep; 78():56-60. PubMed ID: 32731191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study.
    Quattrone A; Morelli M; Vescio B; Nigro S; Le Piane E; Sabatini U; Caracciolo M; Vescio V; Quattrone A; Barbagallo G; Stanà C; Nicoletti G; Arabia G; Nisticò R; Novellino F; Salsone M
    Mov Disord; 2019 Apr; 34(4):487-495. PubMed ID: 30759325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Progressive Supranuclear Palsy Rating Scale with Progressive Supranuclear Palsy Quality of Life Scale.
    Pantelyat A; Higginbotham L; Rosenthal L; Lanham D; Nesspor V; AlSalihi M; Bang J; Wang J; Albert M
    Neurodegener Dis; 2020; 20(4):139-146. PubMed ID: 33789283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential diagnosis between Parkinson's disease and atypical parkinsonism based on gait and postural instability: Artificial intelligence using an enhanced weight voting ensemble model.
    Song J; Kim J; Lee MJ; Ahn JH; Lee DY; Youn J; Chung MJ; Kim Z; Cho JW
    Parkinsonism Relat Disord; 2022 May; 98():32-37. PubMed ID: 35447488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Modified Progressive Supranuclear Palsy Rating Scale for Virtual Assessments.
    Wills AM; Pantelyat A; Espay A; Chan J; Litvan I; Xie T; Dale ML; Gunzler SA; Tartaglia MC; Fox SH; Rodriguez-Porcel F; Sharma M; Lang AE; Boxer AL; ; Golbe LI
    Mov Disord; 2022 Jun; 37(6):1265-1271. PubMed ID: 35363932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased basal ganglia binding of
    Smith R; Schain M; Nilsson C; Strandberg O; Olsson T; Hägerström D; Jögi J; Borroni E; Schöll M; Honer M; Hansson O
    Mov Disord; 2017 Jan; 32(1):108-114. PubMed ID: 27709757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Gait Analysis in Progressive Supranuclear Palsy and Parkinson's Disease.
    Hatanaka N; Sato K; Hishikawa N; Takemoto M; Ohta Y; Yamashita T; Abe K
    Eur Neurol; 2016; 75(5-6):282-9. PubMed ID: 27288001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale.
    Cubo E; Stebbins GT; Golbe LI; Nieves A; Leurgans S; Goetz CG; Kompoliti K
    Mov Disord; 2000 Mar; 15(2):276-9. PubMed ID: 10752576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal spiking in the pedunculopontine nucleus in progressive supranuclear palsy and in idiopathic Parkinson's disease.
    Galazky I; Kaufmann J; Voges J; Hinrichs H; Heinze HJ; Sweeney-Reed CM
    J Neurol; 2019 Sep; 266(9):2244-2251. PubMed ID: 31155683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which ante mortem clinical features predict progressive supranuclear palsy pathology?
    Respondek G; Kurz C; Arzberger T; Compta Y; Englund E; Ferguson LW; Gelpi E; Giese A; Irwin DJ; Meissner WG; Nilsson C; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Josephs KA; Lang AE; Mollenhauer B; Müller U; Whitwell JL; Antonini A; Bhatia KP; Bordelon Y; Corvol JC; Colosimo C; Dodel R; Grossman M; Kassubek J; Krismer F; Levin J; Lorenzl S; Morris H; Nestor P; Oertel WH; Rabinovici GD; Rowe JB; van Eimeren T; Wenning GK; Boxer A; Golbe LI; Litvan I; Stamelou M; Höglinger GU;
    Mov Disord; 2017 Jul; 32(7):995-1005. PubMed ID: 28500752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Balance and eye movement training to improve gait in people with progressive supranuclear palsy: quasi-randomized clinical trial.
    Zampieri C; Di Fabio RP
    Phys Ther; 2008 Dec; 88(12):1460-73. PubMed ID: 18948373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postural strategies assessed with inertial sensors in healthy and parkinsonian subjects.
    Baston C; Mancini M; Schoneburg B; Horak F; Rocchi L
    Gait Posture; 2014; 40(1):70-5. PubMed ID: 24656713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.
    Archer DB; Bricker JT; Chu WT; Burciu RG; McCracken JL; Lai S; Coombes SA; Fang R; Barmpoutis A; Corcos DM; Kurani AS; Mitchell T; Black ML; Herschel E; Simuni T; Parrish TB; Comella C; Xie T; Seppi K; Bohnen NI; Müller ML; Albin RL; Krismer F; Du G; Lewis MM; Huang X; Li H; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
    Lancet Digit Health; 2019 Sep; 1(5):e222-e231. PubMed ID: 33323270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly.
    Fernández-Ferreira R; García-Santos RA; Rodríguez-Violante M; López-Martínez C; Becerra-Laparra IK; Torres-Pérez ME
    Rev Esp Geriatr Gerontol; 2019; 54(5):251-256. PubMed ID: 31324404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory based assessment of gait and balance impairment in patients with progressive supranuclear palsy.
    Ali F; Loushin SR; Botha H; Josephs KA; Whitwell JL; Kaufman K
    J Neurol Sci; 2021 Oct; 429():118054. PubMed ID: 34461552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
    JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spinal cord stimulation therapy for gait dysfunction in progressive supranuclear palsy patients.
    Samotus O; Parrent A; Jog M
    J Neurol; 2021 Mar; 268(3):989-996. PubMed ID: 33011852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study.
    Quattrone A; Morelli M; Quattrone A; Vescio B; Nigro S; Arabia G; Nisticò R; Novellino F; Salsone M; Arcuri P; Luca A; Mazzuca A; Alessio C; Rocca F; Caracciolo M
    Parkinsonism Relat Disord; 2020 Mar; 72():1-6. PubMed ID: 32036297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.
    Ling H; Massey LA; Lees AJ; Brown P; Day BL
    Brain; 2012 Apr; 135(Pt 4):1141-53. PubMed ID: 22396397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.